Catalent, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- None.
- None.
A live webcast of the presentation will be accessible at http://investor.catalent.com and will be available for replay following the event.
About Catalent
Catalent, Inc., is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,500 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply approximately 70 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of nearly 18,000 includes more than 3,000 scientists and technicians. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240104008546/en/
Investor Contact:
Paul Surdez, Catalent, Inc.
(732) 537-6325
investors@catalent.com
Source: Catalent, Inc.
FAQ
What is the company name participating in the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024?
What is the ticker symbol of Catalent, Inc.?
When will the presentation take place at the conference?
Where can the live webcast of the presentation be accessed?